On Jan. 17, 2006, researchers at the University of California, San Diego (UCSD) announced the development of a…
In 2006, Andrew Fire of Stanford Univeristy School of Medicine was awarded the 2006 Nobel Prize in Physiology…
In 2006, San Diego Consortium for Regenerative Medicine was established as a California non-profit corporation and a 501(c)(3)…
On Dec. 15, 2005, Integrated DNA Technologies (IDT) announced the completion of its acquisition of San Diego, CA…
On Nov. 10, 2005, Stanford researchers announced they had discovered obestatin, a hormone that suppresses appetite. The discovery…
On Sept. 26, 2005, San Diego business leader and philanthropist John J. Moores contributed $4 million to The…
On Jun. 22, 2005, the Fred Hutchinson Business Alliance announced that the 2005 E. Donnall Thomas Medal of…
On Apr. 8, 2005, Moores Cancer Center (MCC) at University of California, San Diego opened its new consolidated…
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
On Mar. 1, 2005, the American Chemical Society awarded the Priestley Medal to George A. Olah “to recognize…
In 2005, the California Institute for Regenerative Medicine (CIRM) was formally established following the passage of Proposition 71…
On Dec. 15, 2004, Amgen announced that following priority review, the FDA has approved Kepivance(TM) (palifermin), the first…
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
On Mar. 19, 2004, University of California, San Diego (UCSD) was awarded $7.5 million to establish The Kavli…
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
In 2004, Touro University Nevada (TUN), located in Henderson, was founded as a private, non-profit institution of higher…
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On Aug. 25, 2003, the FDA approved an expanded indication for ENBREL (etanercept) to inhibit the progression of…
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
On Jun. 16, 2003, researchers at Stanford University Medical Center announced they found that a drug commonly prescribed…
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…
On Apr. 27, 2003, Stanford researchers found that Wnt genes, first discovered as critical genes in cancer, are…
On Apr. 1, 2003, the birth of a cloned banteng from a surrogate mother cow was announced by…
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
In 2003, The Institute for Collaborative Biotechnologies (ICB) was founded as an Army-sponsored University Affiliated Research Center (UARC)….
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
On Aug. 5, 2002, President George W. Bush appointed Richard H. Carmona as U.S. Surgeon General, one of…